酵素補充療法の世界市場規模調査・予測：製品別、疾患別（ゴーシェ病、ファブリー病、ポンペ病、ムコ多糖症、膵外分泌不全（EPI）、その他）、エンドユーザー別、地域別分析、2022-2029年

酵素補充療法」とは、先天性酵素欠乏症を治療するために、ヒト、動物、または組み換え酵素を使用する医療行為を指します。

ERTの基本原理は、酵素が欠乏している人に人工酵素を補充することです。ERTでは、経口投与と静脈内投与の方法が広く利用されています。市場の成長を促進する重要な要因は、希少疾患の有病率の上昇、酵素補充療法の広い範囲の可用性と希少疾患のための政府のイニシアチブの上昇です。このため、予測期間中に市場に対する有利な需要が創出されます。

希少なライソゾーム貯蔵病を患う患者層が多く存在することで、酵素補充療法などの効果的な治療に対する高い需要が生まれます。ゴーシェ、ファブリー、ポンペ、MPSなど、いくつかのリソソーム貯蔵疾患の有病率は、世界レベルで徐々に上昇しています。例えば、Cleveland Clinicが発表したデータによると、2020年には米国で6,000人がゴーシェ病を発症し、そのうち95％が1型ゴーシェ病であるとされています。また、希少疾患の診断率が徐々に高まっているのは、政府の取り組みや各国のNPOが国民の意識を高めるために努力を重ねている結果でもあります。その結果、これらの主な点に加え、先進国における有利な保険償還政策や医療に対する政府の支援が、この治療法の採用率を高め、結果として予測期間中の市場拡大を後押ししています。また、酵素補充療法に対する社会的認知度の向上も、予測期間中に同市場に有利な機会をもたらすと思われます。しかし、酵素補充療法はコストが高いため、2022年から2029年の予測期間を通じて市場の成長を阻害します。

酵素補充療法の世界市場調査のために考慮された主要な地域は、アジア太平洋、北米、欧州、中南米、および世界のその他の地域が含まれています。北米は、主要な市場プレイヤーの存在と、同地域で整備されたヘルスケアインフラにより、市場シェアの点で世界を支配する地域となっています。一方、アジア太平洋地域は、希少疾患に苦しむ患者数の増加や、民間団体や政府による酵素補充療法に関する啓発活動の活発化などの要因から、予測期間中に高い成長率を示すと予想されます。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むことを目的としています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • 酵素補充療法市場：地域別、2019-2029年
  • 酵素補充療法市場：製品別、2019-2029年
  • 酵素補充療法市場：疾患別、2019-2029年
  • 酵素補充療法市場：エンドユーザー別、2019-2029年
• 主な動向
• 調査手法
• 調査前提条件

第2章 酵素補充療法の世界市場定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 世界の酵素補充療法市場力学

• 酵素補充療法市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 希少疾病の有病率の上昇
    • 幅広い種類の酵素補充療法の利用可能性
  • 市場の課題
    • 高い治療費
  • 市場機会
    • 酵素補充療法に関する社会的認知度の上昇

第4章 世界の酵素補充療法市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• トップ投資機会
• 主要成功戦略
• 業界専門家別展望
• アナリストの結論・提言

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 酵素補充療法の世界市場：製品別

• 市場スナップショット
• 酵素補充療法の世界市場：製品別、業績-ポテンシャル分析
• 酵素補充療法の世界市場製品別推定・予測2019-2029
• 酵素補充療法市場、サブセグメント分析
  • アガルシダーゼベータ
  • イミグルシダーゼ
  • ベラグルセラーゼ・アルファ
  • イドゥルスルファーゼ
  • ガルスルファ-ゼ
  • ラロニダーゼ
  • その他

第7章 酵素補充療法の世界市場：疾患別

• 市場スナップショット
• 酵素補充療法の世界市場：疾患別、業績-ポテンシャル分析
• 酵素補充療法の世界市場、疾患別推定・予測2019-2029年
• 酵素補充療法市場、サブセグメント分析
  • ゴーシェ病
  • ファブリー病
  • ポンペ病
  • ムコポリサッカリドーシス
  • 外分泌膵不全症（EPI）
  • その他

第8章 酵素補充療法の世界市場：エンドユーザー別

• 市場スナップショット
• 酵素補充療法の世界市場：エンドユーザー別実績-ポテンシャル分析
• 酵素補充療法の世界市場、エンドユーザー別推定・予測2019-2029年
• 酵素補充療法市場、サブセグメント分析
  • 病院
  • インフュージョンセンター＆ホームヘルスケアセッティング

第9章 酵素補充療法の世界市場：地域別分析

• 酵素補充療法市場：地域別市場スナップショット
• 北米
  • 米国
    • 製品別の推定・予測、2019-2029年
    • 疾患別の推定・予測、2019年～2029年
    • エンドユーザー別の推定・予測、2019年～2029年
  • カナダ
• 欧州酵素補充療法市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の酵素補充療法市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの酵素補充療法市場スナップショット
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ地域
• 世界のその他の地域

第10章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Abbvie Inc.
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Astrazeneca Plc
  • Biomarin Pharmaceutical In
  • Chiesi Farmaceutici S.P.A.
  • Digestive Care, Inc.
  • Leadiant Biosciences, Inc.
  • Nestle Health Science
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceuticals

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Enzyme Replacement Therapy Market, report scope
• TABLE 2. Global Enzyme Replacement Therapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Enzyme Replacement Therapy Market estimates & forecasts by Product 2019-2029 (USD Billion)
• TABLE 4. Global Enzyme Replacement Therapy Market estimates & forecasts by Disease 2019-2029 (USD Billion)
• TABLE 5. Global Enzyme Replacement Therapy Market estimates & forecasts by End User 2019-2029 (USD Billion)
• TABLE 6. Global Enzyme Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Enzyme Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Enzyme Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Enzyme Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Enzyme Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Enzyme Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Enzyme Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Enzyme Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Enzyme Replacement Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Enzyme Replacement Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Enzyme Replacement Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Enzyme Replacement Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Enzyme Replacement Therapy Market
• TABLE 71. List of primary sources, used in the study of global Enzyme Replacement Therapy Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Enzyme Replacement Therapy Market, research methodology
• FIG 2. Global Enzyme Replacement Therapy Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Enzyme Replacement Therapy Market, key trends 2021
• FIG 5. Global Enzyme Replacement Therapy Market, growth prospects 2022-2029
• FIG 6. Global Enzyme Replacement Therapy Market, porters 5 force model
• FIG 7. Global Enzyme Replacement Therapy Market, pest analysis
• FIG 8. Global Enzyme Replacement Therapy Market, value chain analysis
• FIG 9. Global Enzyme Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Enzyme Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Enzyme Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Enzyme Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Enzyme Replacement Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Enzyme Replacement Therapy Market, regional snapshot 2019 & 2029
• FIG 15. North America Enzyme Replacement Therapy Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Enzyme Replacement Therapy Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Enzyme Replacement Therapy Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Enzyme Replacement Therapy Market 2019 & 2029 (USD Billion)
• FIG 19. Global Enzyme Replacement Therapy Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Enzyme Replacement Therapy Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. The "enzyme replacement therapy" refers to a medical procedure that uses human, animal, or recombinantly engineered enzymes to treat congenital enzyme deficiencies. The ERT core principle is the replacement of artificial enzyme in those with an enzyme deficiency. For ERT, the oral and intravenous methods of administration are widely utilized. The key factor driving the market growth is rising prevalence of rare diseases, availability of a wide range of enzyme replacement therapy and rising government initiatives for rare diseases. Thus, create the lucrative demand for the market during forecast period.

The presence of a large patient population suffering from rare lysosomal storage diseases creates high demand for effective treatments such as enzyme replacement therapy. The prevalence of several lysosomal storage disorders such Gaucher, Fabry, Pompe, and MPS is gradually rising on a global level. For instance, according to data released by Cleveland Clinic, in 2020, 6,000 persons in the United States have Gaucher disease, with 95% of them having type 1 Gaucher. A gradual increase in the diagnosis rate of rare diseases is also a result of growing government efforts and non-profit organizations in various nations to raise public awareness. As a result, these key aspects, as well as advantageous reimbursement policies and government support for medical care in developed nations, are increasing the rate of this therapy's adoption and, as a result, propelling the market's expansion over the projection period. Also, rising public awareness about enzyme replacement therapies would create the lucrative opportunities for the market during forecast period. However, the high cost of Enzyme Replacement Therapy stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Enzyme Replacement Therapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players and well-developed healthcare infrastructure in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising number of patients suffering from rare disorders and growing initiatives by other private organizations and the government for the awareness about this therapy would create lucrative growth prospects for the Enzyme Replacement Therapy market across Asia Pacific region.

Major market players included in this report are:

Abbvie Inc.

Astrazeneca Plc

Biomarin Pharmaceutical In

Chiesi Farmaceutici S.P.A.

Digestive Care, Inc.

Leadiant Biosciences, Inc.

Nestle Health Science

Pfizer Inc.

Sanofi S.A.

Takeda Pharmaceuticals

Recent Developments in the Market:

• In 2021, Takeda Pharmaceutical Co. Ltd. announced a partnership deal with JCR Pharmaceuticals Co., Ltd., intending to commercialise JR-141 outside the U.S. to treatment of hunter syndrome.
• In 2021, Clinigen Group plc. announced the manufacturing and distribution approval for hunterase ICV throughout Japan to treat patients with Hunter syndrome.

Global Enzyme Replacement Therapy Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Disease, End User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Agalsidase Beta

Imiglucerase

Velaglucerase Alfa

Idursulfase

Galsulfase

Laronidase

Others

By Disease:

Gaucher Disease

Fabry Disease

Pompe Disease

Mucopolysaccharidosis

Exocrine Pancreatic Insufficiency (EPI)

Others

By End User:

Hospitals

Infusion Centers & Home Healthcare Setting

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Enzyme Replacement Therapy Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Enzyme Replacement Therapy Market, by Product, 2019-2029 (USD Billion)
  • 1.2.3. Enzyme Replacement Therapy Market, by Disease, 2019-2029 (USD Billion)
  • 1.2.4. Enzyme Replacement Therapy Market, by End User, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Enzyme Replacement Therapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Enzyme Replacement Therapy Market Dynamics

• 3.1. Enzyme Replacement Therapy Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising prevalence of rare diseases
    • 3.1.1.2. Availability of a wide range of enzyme replacement therapy
  • 3.1.2. Market Challenges
    • 3.1.2.1. High cost of treatment
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising public awareness about enzyme replacement therapies

Chapter 4. Global Enzyme Replacement Therapy Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Enzyme Replacement Therapy Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Enzyme Replacement Therapy Market by Product, Performance - Potential Analysis
• 6.3. Global Enzyme Replacement Therapy Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
• 6.4. Enzyme Replacement Therapy Market, Sub Segment Analysis
  • 6.4.1. Agalsidase Beta
  • 6.4.2. Imiglucerase
  • 6.4.3. Velaglucerase Alfa
  • 6.4.4. Idursulfase
  • 6.4.5. Galsulfase
  • 6.4.6. Laronidase
  • 6.4.7. Others

Chapter 7. Global Enzyme Replacement Therapy Market, by Disease

• 7.1. Market Snapshot
• 7.2. Global Enzyme Replacement Therapy Market by Disease, Performance - Potential Analysis
• 7.3. Global Enzyme Replacement Therapy Market Estimates & Forecasts by Disease 2019-2029 (USD Billion)
• 7.4. Enzyme Replacement Therapy Market, Sub Segment Analysis
  • 7.4.1. Gaucher Disease
  • 7.4.2. Fabry Disease
  • 7.4.3. Pompe Disease
  • 7.4.4. Mucopolysaccharidosis
  • 7.4.5. Exocrine Pancreatic Insufficiency (EPI)
  • 7.4.6. Others

Chapter 8. Global Enzyme Replacement Therapy Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Enzyme Replacement Therapy Market by End User, Performance - Potential Analysis
• 8.3. Global Enzyme Replacement Therapy Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
• 8.4. Enzyme Replacement Therapy Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Infusion Centers & Home Healthcare Setting

Chapter 9. Global Enzyme Replacement Therapy Market, Regional Analysis

• 9.1. Enzyme Replacement Therapy Market, Regional Market Snapshot
• 9.2. North America Enzyme Replacement Therapy Market
  • 9.2.1. U.S. Enzyme Replacement Therapy Market
    • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Disease breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Enzyme Replacement Therapy Market
• 9.3. Europe Enzyme Replacement Therapy Market Snapshot
  • 9.3.1. U.K. Enzyme Replacement Therapy Market
  • 9.3.2. Germany Enzyme Replacement Therapy Market
  • 9.3.3. France Enzyme Replacement Therapy Market
  • 9.3.4. Spain Enzyme Replacement Therapy Market
  • 9.3.5. Italy Enzyme Replacement Therapy Market
  • 9.3.6. Rest of Europe Enzyme Replacement Therapy Market
• 9.4. Asia-Pacific Enzyme Replacement Therapy Market Snapshot
  • 9.4.1. China Enzyme Replacement Therapy Market
  • 9.4.2. India Enzyme Replacement Therapy Market
  • 9.4.3. Japan Enzyme Replacement Therapy Market
  • 9.4.4. Australia Enzyme Replacement Therapy Market
  • 9.4.5. South Korea Enzyme Replacement Therapy Market
  • 9.4.6. Rest of Asia Pacific Enzyme Replacement Therapy Market
• 9.5. Latin America Enzyme Replacement Therapy Market Snapshot
  • 9.5.1. Brazil Enzyme Replacement Therapy Market
  • 9.5.2. Mexico Enzyme Replacement Therapy Market
  • 9.5.3. Rest of Latin America Enzyme Replacement Therapy Market
• 9.6. Rest of The World Enzyme Replacement Therapy Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Abbvie Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Astrazeneca Plc
  • 10.2.3. Biomarin Pharmaceutical In
  • 10.2.4. Chiesi Farmaceutici S.P.A.
  • 10.2.5. Digestive Care, Inc.
  • 10.2.6. Leadiant Biosciences, Inc.
  • 10.2.7. Nestle Health Science
  • 10.2.8. Pfizer Inc.
  • 10.2.9. Sanofi S.A.
  • 10.2.10. Takeda Pharmaceuticals

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption